Danushis Chemicals - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,005,444 | 2,028,733 | 4,132,949 | 2,513,940 | 3,418,273 | 3,293,854 | 3,305,420 | 3,255,634 |
| Profit before tax | 171,501 | 295,438 | 1,639,589 | 379,432 | 771,129 | 768,959 | 755,594 | 582,077 |
| Net profit | 146,499 | 250,987 | 1,393,372 | 337,888 | 653,923 | 657,324 | 642,142 | 522,794 |
| Equity | 1,276,916 | 1,527,903 | 2,021,275 | 2,359,163 | 3,021,104 | 3,678,427 | 4,320,569 | 4,843,363 |
| Liabilities | 120,564 | 103,724 | 424,384 | 265,293 | 346,380 | 272,652 | 210,042 | 275,532 |
| Non-current assets | 145,425 | 123,017 | 190,285 | 539,597 | 477,971 | 782,821 | 1,882,167 | 2,784,980 |
| Current assets | 1,252,055 | 1,508,610 | 2,258,760 | 2,373,242 | 3,086,057 | 3,290,116 | 2,688,344 | 2,333,915 |
| Total assets | 1,397,480 | 1,631,627 | 2,449,045 | 2,912,839 | 3,564,028 | 4,072,937 | 4,570,511 | 5,118,895 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 473,985 | 375,934 | 336,255 |
| Social insurance contributions | - | - | - | - | - | 45,453 | 59,569 | 65,674 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.0% | +1.2% | +103.7% | -39.2% | +36.0% | -3.6% | +0.4% | -1.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 10.5% | 15.4% | 56.9% | 11.6% | 18.3% | 16.1% | 14.0% | 10.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 11.5% | 16.4% | 68.9% | 14.3% | 21.6% | 17.9% | 14.9% | 10.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.3% | 12.4% | 33.7% | 13.4% | 19.1% | 20.0% | 19.4% | 16.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.6% | 14.6% | 39.7% | 15.1% | 22.6% | 23.3% | 22.9% | 17.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 92,916 | 102,289 | 201,607 | 130,594 | 184,772 | 178,851 | 184,488 | 193,404 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Danushis Chemicals - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 487.59 |
Danushis Chemicals - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Danushis Chemicals, UAB (code 140692326) is a Private Limited Liability Company engaged in the manufacture of other chemical products n.e.c. In the latest financial year, 2025, the company generated revenue of EUR 3.26 million and net profit of EUR 522.8 thousand, with a profit margin of 16.1%. Revenue eased slightly by 1.5% year on year, while the two-year change was also slightly negative at 1.2%, indicating a broadly stable top line over the period. Profitability softened from the 2023–2024 level, when net profit was above EUR 640 thousand and margin was around 19%–20%. Even so, the business remained profitable and produced a return on equity of 10.8% and return on assets of 10.2% in 2025. The balance sheet was conservatively structured, with total assets of EUR 5.12 million, equity of EUR 4.84 million and liabilities of EUR 275.5 thousand. Equity accounted for 94.6% of assets, and debt-to-equity was 0.06. Revenue per employee was EUR 203.5 thousand, with profit per employee of EUR 32.7 thousand.